PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Target CCL14 34 6 0.00 -0.91 0.18 0.55
Carcinoma 433,099 Disease Target Erbb2 4,536 793 0.02 -0.91 0.17 0.61
Carcinoma 433,099 Disease Target DAPK1 205 36 0.00 -0.91 0.18 0.58
Thromboembolism 23,698 Disease Target D-Dimer 6,185 887 0.07 -0.91 0.14 0.75
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target Endoglin 1,333 232 0.01 -0.91 0.17 0.57
CXCL7 76 Target Target CXCL3 145 9 0.09 -0.91 0.12 0.84
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Breast Cancer 173,695 Disease Target ERBB3 1,154 198 0.01 -0.91 0.17 0.63
EPHA4 357 Target Target EPHA3 140 18 0.08 -0.91 0.13 0.82
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
CNTF 1,613 Target Target Cardiotrophin-1 351 51 0.07 -0.91 0.15 0.78
Cholesterol 182,390 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.60
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ETS1 539 92 0.00 -0.91 0.17 0.56
CKMM 55 Target Target CKBB 57 5 0.09 -0.91 0.09 0.86
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
CCL5 2,002 Target Target CCL1 220 34 0.05 -0.91 0.15 0.76
Collagen 138,882 Target Target Complement Component C1q 167 28 0.01 -0.91 0.17 0.61
Carcinoma 433,099 Disease Target EPHA2 532 89 0.01 -0.91 0.17 0.59
BMP-2B 18 Target Target BMP-2 3,889 3 0.01 -0.91 0.17 0.68
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
Doxanthrine 6 Drug Target D(2) Dopamine Receptor 1,559 1 0.01 -0.91 0.17 0.69
CD4 112,219 Target Target CD95 4,266 691 0.03 -0.91 0.16 0.66
CAMK2A 42 Target Target Calmodulin 25,240 7 0.01 -0.91 0.17 0.64
Kadsurin 6 Drug Target CCL4 5,638 1 0.01 -0.91 0.17 0.66
Personality Disorders 6,349 Disease Target CTAP-3 6 1 0.01 -0.91 0.17 0.66
Chagas Disease 8,212 Disease Target Glutaminyl-Peptide Cyclotransferase 6 1 0.00 -0.91 0.17 0.65
Alcohol Dehydrogenase 8,492 Target Target Microsomal Glutathione S-Transferase 2 6 1 0.00 -0.91 0.17 0.65
Kadsurin 6 Drug Target Platelet Activating Factor 9,915 1 0.00 -0.91 0.17 0.64
Shock 134,031 Disease Target DNA-damage-inducible transcript 3 30 5 0.00 -0.91 0.17 0.60
Osteoporosis 46,215 Disease Target Glutaminyl-Peptide Cyclotransferase 6 1 0.00 -0.91 0.17 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Target Collagen 138,882 3 0.00 -0.91 0.17 0.59
Schizophrenia 77,034 Disease Target CTAP-3 6 1 0.00 -0.91 0.17 0.60
CTAP-3 6 Target Target Collagen 138,882 1 0.00 -0.91 0.17 0.58
Diabetes 332,602 Disease Target Neutral Alpha-Glucosidase C 6 1 0.00 -0.91 0.17 0.57
Carcinoma 433,099 Disease Target Glutaminyl-Peptide Cyclotransferase 6 1 0.00 -0.91 0.17 0.56
Infection 766,637 Disease Target Glutaminyl-Peptide Cyclotransferase 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target E9 protein 6 1 0.00 -0.91 0.17 0.55
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
Infection 766,637 Disease Target CXCL11 526 86 0.00 -0.91 0.16 0.57
Diabetes 332,602 Disease Target Insulin-Degrading Enzyme 558 91 0.01 -0.91 0.16 0.60
Cancer 1,053,491 Disease Target ERK1 18,374 2,955 0.02 -0.91 0.16 0.59
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
Inflammation 252,734 Disease Target CCL21 808 130 0.01 -0.92 0.16 0.61
Obesity 138,233 Disease Target APOA2 118 19 0.00 -0.92 0.16 0.61
CCL5 2,002 Target Target CXCL3 145 22 0.04 -0.92 0.15 0.75
Macrophage Metalloelastase 100 Target Target Elastase 13,875 16 0.01 -0.92 0.16 0.67
Infection 766,637 Disease Target CCL2 3,560 569 0.01 -0.92 0.16 0.59
CCL4 5,638 Target Target CCL1 220 34 0.03 -0.92 0.15 0.72
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
CD4 112,219 Target Target Tegument Protein Vp16 19 3 0.00 -0.92 0.16 0.60
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
CD4 112,219 Target Target CXCL9 1,016 159 0.01 -0.92 0.16 0.64
CCL3 1,427 Target Target CXCL3 145 21 0.05 -0.92 0.14 0.76
CD4 112,219 Target Target CCL21 808 126 0.01 -0.92 0.16 0.63
Leukemia 162,805 Disease Target CD34 24,598 3,403 0.05 -0.92 0.14 0.68
Cancer 1,053,491 Disease Target CCL18 256 40 0.00 -0.92 0.16 0.56
CCL19 658 Target Target CD4 112,219 102 0.01 -0.92 0.16 0.63
Cancer 1,053,491 Disease Target Methylenetetrahydrofolate Reductase 3,573 555 0.01 -0.92 0.16 0.58
APOH 110 Target Target APOE 12,771 17 0.01 -0.92 0.15 0.67
Adenosine A3 Receptor 164 Target Target Adenosine A1 Receptor 1,432 23 0.05 -0.92 0.14 0.76
Depression 220,092 Disease Target Dopamine Reuptake 540 83 0.01 -0.92 0.15 0.61
ERK1 18,374 Target Target ATF-2 Protein 13 2 0.00 -0.92 0.15 0.63
Hearing Loss 30,622 Disease Target Glutathione Peroxidase 6 13 2 0.00 -0.92 0.15 0.62
Schizophrenia 77,034 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.60
Anxiety 113,510 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.59
Cancer 1,053,491 Disease Target Hyaluronidase-1 52 8 0.00 -0.92 0.15 0.55
Pain 409,851 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target AURKC 26 4 0.00 -0.92 0.15 0.55
Deep Vein Thrombosis 10,952 Disease Target D-Dimer 6,185 630 0.08 -0.92 0.10 0.77
CD4 112,219 Target Target CD14 9,941 1,398 0.04 -0.92 0.14 0.68
Carcinoma 433,099 Disease Target Cytokeratin 18 1,108 167 0.01 -0.92 0.15 0.59
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
Cancer 1,053,491 Disease Target Chorionic Gonadotropin beta 936 141 0.00 -0.92 0.15 0.56
BD2 76 Target Target BD4 26 3 0.07 -0.92 0.12 0.82
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
Schizophrenia 77,034 Disease Target 5-Hydroxytryptamine 2a Receptor 67 10 0.00 -0.92 0.15 0.61
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
CRG-2 41 Target Target CXCL10 2,386 6 0.02 -0.92 0.15 0.71
CCL14 34 Target Target CCL2 3,560 5 0.01 -0.92 0.15 0.69
CD4 112,219 Target Target Exodus-2 27 4 0.00 -0.92 0.15 0.60
BMP-6 386 Target Target Collagen 138,882 57 0.01 -0.92 0.15 0.62
BAFFR 44 Target Target BLyS 457 6 0.04 -0.92 0.14 0.77
CCL4 5,638 Target Target CCL8 197 28 0.03 -0.92 0.14 0.71
CD4 112,219 Target Target CRG-2 41 6 0.00 -0.92 0.15 0.60
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Infection 766,637 Disease Target CCL1 220 32 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target CLK1 62 9 0.00 -0.92 0.15 0.55
CD31/PECAM1 7 Target Target EPHB2 385 1 0.02 -0.92 0.14 0.73
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
BMP-7 1,112 Target Target BMP-14 14 2 0.02 -0.92 0.14 0.71
Alpha-Glucosidase 4,319 Target Target Pancreatic Alpha-Amylase 423 56 0.04 -0.93 0.13 0.74